Scott Wine, Polaris Industries CEO, discusses Polaris' earnings and if their outperformance is sustainable. Wine says he did not see weather as a negative impact to sales.» Read More
Thomas Strauss, Cowen Group vice chairman, explains why he believes fixed income prices are high, and it's time for investors to consider moving into equities.
How is small business feeling about the state of the economy? CNBC's Steve Liesman, and Bill Dunkelberg, National Federation of Independent Business, break down the results from the latest NFIB Survey.
Sen. Ron Johnson, (R-WI); and John Allison, Cato president, explain how fiscal uncertainty is impacting the business environment.
Marc Faber, "The Gloom Boom & Doom Report," explains why he owns gold and would look at Vietnam, China and Japan for investment opportunities this year.
A look at what traders will be watching ahead of the opening bell, with Kevin Ferry, Cronus Futures Management.
Time to rethink global equities? Russ Koesterich, BlackRock chief investment strategist, discusses where investors are likely to find opportunities in the year ahead.
Drew Matus, UBS senior U.S. economist, explains why the Fed would not monetize a platinum coin, and provides an outlook on the markets for 2013.
CNBC's Kelly Evans tells you what the markets will be watching as we approach the start of trading in the U.S.
Earnings season unofficially kicks off Tuesday. From Sandy to the "fiscal cliff" get ready to here every excuse in the book for weak profits and revenue!
The Dow Jones average and the S&P 500 dropped slightly in today's trading, with Jonathan Golub, UBS chief U.S. equity strategist.
Ajay Kapur, Head of Equity Strategy, Asia, Deutsche Bank thinks 2013 will be a good year for equities. He expects 10-15% upside for Asian markets and 10% growth in EPS.
Mad Money host Jim Cramer shares his final thoughts of the day.
Exact Sciences' CEO Kevin Conroy weighs in on the Medicare spending talks in Washington, and discusses his company's development of non-invasive ways to detect colorectal cancer.
Mad Money host Jim Cramer begins the annual stock Super Bowl by pitting the best performers in the Dow Jones average against each other.
NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.
Mad Money host Jim Cramer explains why it's important to find market themes that will withstand the test of circumstances surrounding the markets. "Themes are the quintessential non-risk on risk off investment that you can fall back on when the market sells off," he says.
The biggest predictions of 2013, including Procter & Gamble, Ford and Apple, with Doug Kass, president and founder of Seabreeze Partners. The Fast Money traders, weigh in.
The CDC says this is the most aggressive early flu season in 8 years. Discussing which under-the-weather trades could lead to some healthy profits, with the Fast Money traders; and Dan Hurwitz, DDR CEO, discusses the winners and losers in retail now, and what's next for DDR.
Matt Rubin, CIO, Neuberger Berman Trust advises investors to look at individual companies with attractive valuations and emerging market exposure to weather any economic "storms".
Matt Rubin, CIO, Neuberger Berman Trust says that some U.S. earnings this season will surprise to the upside, with corporate balance sheets looking good.